Porcentaje de pacientes con hipertensión arterial esencial controlada en dos hospitales de la Ciudad de México

Contenido principal del artículo

Eros Balam Ortiz
Omar Eloy Muñoz Monroy
Sandra Rodríguez
Francisco Barajas Olmos
Adolfo Esquivel Villarreal
David Huerta Hernández
Ángel Sergio Olivares Morales
Luis Alfaro Ruiz
Enrique Figueroa Genis
José Luis Ojeda Delgado

Resumen

La hipertensión arterial sistémica es un problema de salud nacional. El control adecuado de las cifras de presión arterial (< 140/90 mmHg) es uno de los retos al que se enfrentan el clínico y el paciente.

Detalles del artículo

Sección

Artículos de investigación

Cómo citar

1.
Porcentaje de pacientes con hipertensión arterial esencial controlada en dos hospitales de la Ciudad de México. RSM [Internet]. 2025 Apr. 10 [cited 2026 Feb. 4];68(1). Available from: https://www.revistasanidadmilitar.org/index.php/rsm/article/view/2579

Referencias

Olaiz-Fernández G, Rivera-Dommarco J, Sepúlveda-Amor J. Encuesta Nacional de Salud y Nutrición 2006. Cuernavaca, México: Instituto Nacional de Salud Pública; 2006.

Farley TA, Dalal MA, Mostashari F, Frieden TR. Deaths presentable in the US by improvements in use of clinical preventive service. Am J Prev Med 2010; 38: 606-9.

Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure and National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289: 2560-72.

Wolf-Maier K, Cooper R, Kramer H, Banegas J, Giampaoli S, Joffres M, Poulter N, et al. Hypertension Treatment and Control in Five European Countries, Canada, and the United States. Hypertension 2004; 43: 10-17.

Velázquez MO, Rosas PM, Lara EA, Pastelín HG. Hipertensión arterial en México: Resultados de la Encuesta Nacional de Salud (ENSA) 2000. Arch Cardiol Mex 2002; 72: 71-84.

Barquera S, Campos-Nonato I, Hernández-Barrera L, Villalpando S, Rodríguez-Gilabert C, Durazo-Arvizú R, Aguilar-Salinas C. Hypertension in Mexican adults: results from the National Health and Nutrition Survey 2006. Salud Publica Mex 2010; 52: S63-S71.

Arredondo A, Zúñiga A. Epidemiologic changes and economic burden of hypertension in Latin America: evidence from Mexico. Am J Hypertens 2006; 19: 553-9.

Bakris GL, Williams M, Dworkin L et al. Preserving renal function in adults with hypertension and diabetes: a consensus approach. Am J Kidney Dis 2000; 36: 646-61.

Cushman WC, Ford CE, Cutler JA, et al. Success and predictors of blood pressure control in diverse North American settings: the Antihypertensive and LipidLowering treatment to prevent Herat Attack Trial (ALLHAT). J Clin Hypertens 2004; 4: 393-404.

Black HR, Elliott WJ, Grandits G, et al. Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial. JAMA 2003; 289: 2073-2082.

Ong K, Cheung B, Man Y, Lau C, Lam K. Prevalence, Awareness, Treatment, and Control of Hypertension Among United States Adults 1999-

Hypertension 2007; 49: 69-75.

Hajjar I, Kotchen T. Trends in Prevalence, Awareness, Treatment, and Control of Hypertension in the United States, 1988-2000. JAMA 2003;

: 199-206.

Barquera S, Durazo-Arvizu R, Luke A, Cao G, Cooper R. Hypertension in Mexico and among Mexican Americans: prevalence and treatment patterns Hypertension among Mexican descendents. Journal of Human Hypertension 2008; 22: 617-26.

Izzo JL Jr, Levy D, Black HR. Importance of systolic blood pressure in older Americans. Hypertension 2000; 35: 1021-4.

Hyman D, Pavlik V. Characteristics of patients with uncontrolled hypertension in United States. N Engl J Med 2001; 345: 479-86.

Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Prospective Studies Collaboration. Lancet 2002; 360: 1903-13.

Vasan RS, Larson MG, Leip EP, Evans JC, O'Donnell CJ, Kannel WB, et al. Impact of high normal blood pressure on the risk of cardiovascular disease. N Engl J Med 2001; 345: 1291-7.

The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002; 288: 2981-97.

Ong K, Cheung B, Man Y, Lau C, Lam K. Prevalence, Awareness, Treatment, and Control of Hypertension Among United States Adults 1999-2004. Hypertension 2007; 49: 69-75.

Isaza C, Moncada J, Mesa G, Osorio F. Efectividad del tratamiento antihipertensivo en una muestra de pacientes colombianos. Biomédica 2004; 24; 273-281.

Artículos más leídos del mismo autor/a

<< < 1 2 3 4 > >>